U.S. Markets open in 1 hr 47 mins

MusclePharm Corporation (MSLP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.35-0.05 (-3.57%)
At close: 3:59PM EDT
People also watch
CDXCCOCPPGLCOPKCGIX
Full screen
Previous Close1.40
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume18,651
Market Cap19.52M
Beta2.91
PE Ratio (TTM)-675.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
    Capital Cube20 hours ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017
    Capital Cube3 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
    Capital Cube5 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis MusclePharm Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of MusclePharm Corp. – Natural Alternatives International, Inc., GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (NAII-US, GNC-US, MYL-US and BMY-US) that have also reported for this ... Read more (Read more...)